We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+26.16%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$11.4B
AUM Growth
+$1.76B
(+18%)
Cap. Flow
-$330M
Cap. Flow
% of AUM
-2.89%
Top 10 Holdings %
Top 10 Hldgs %
18.38%
Holding
1,151
New
138
Increased
341
Reduced
503
Closed
146
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$32.1M |
| 2 |
Intel
INTC
|
+$28.7M |
| 3 |
Gilead Sciences
GILD
|
+$27.7M |
| 4 |
APA Corp
APA
|
+$27.5M |
| 5 |
Costco
COST
|
+$25.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OPTU
Optimum Communications Inc
OPTU
|
+$41M |
| 2 |
Align Technology
ALGN
|
+$38.9M |
| 3 |
Qualcomm
QCOM
|
+$33.6M |
| 4 |
H&R Block
HRB
|
+$31.8M |
| 5 |
CBRE Group
CBRE
|
+$28.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.64% |
| 2 | Healthcare | 14.08% |
| 3 | Consumer Discretionary | 13.88% |
| 4 | Financials | 13.05% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Minerva Neurosciences
NERV
$191M
| $1.38M | 0.01% |
73,679
+21,291
| +41% | +$536K |
|
652
Bank of Marin Bancorp
BMRC
$460M
| $1.37M | 0.01% |
39,939
-5,993
| -13% | -$204K |
|
|
LBAI
653
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.35M | 0.01% |
106,581
-3,159
| -3% | -$37.2K |
|
654
Community Trust Bancorp
CTBI
$1.42B
| $1.35M | 0.01% |
36,416
| – | – |
|
|
HOLX
655
DELISTED
Hologic
HOLX
| $1.34M | 0.01% |
18,420
-5,916
| -24% | -$418K |
|
656
Altisource Portfolio Solutions
ASPS
$58.4M
| $1.34M | 0.01% |
13,007
+2,422
| +23% | +$250K |
|
|
PVLA
657
Palvella Therapeutics
PVLA
$2.05B
| $1.34M | 0.01% |
6,680
+1,909
| +40% | +$397K |
|
|
SNR
658
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $1.33M | 0.01% |
257,353
+3,942
| +2% | +$19.3K |
|
659
Bassett Furniture
BSET
$169M
| $1.33M | 0.01% |
66,317
+47,489
| +252% | +$803K |
|
|
SYRS
660
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.33M | 0.01% |
12,260
+6,151
| +101% | +$561K |
|
|
FRTA
661
DELISTED
Forterra, Inc
FRTA
| $1.32M | 0.01% |
76,551
+37,683
| +97% | +$603K |
|
662
HNI Corp
HNI
$3.08B
| $1.31M | 0.01% |
38,024
+14,459
| +61% | +$520K |
|
|
SCTL
663
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.29M | 0.01% |
451,301
+140,671
| +45% | +$317K |
|
664
Nektar Therapeutics
NKTR
$2.39B
| $1.28M | 0.01% |
5,032
-87
| -2% | -$22.5K |
|
|
YARW
665
Yarrow Bioscience, Inc. Common Stock
YARW
$20.3M
| $1.28M | 0.01% |
225
+109
| +94% | +$685K |
|
666
Crinetics Pharmaceuticals
CRNX
$8.88B
| $1.25M | 0.01% |
+88,644
| New | +$1.23M |
|
667
Bloomin' Brands
BLMN
$754M
| $1.25M | 0.01% |
64,144
-2,956
| -4% | -$50.4K |
|
668
Myriad Genetics
MYGN
$476M
| $1.24M | 0.01% |
62,922
-711,567
| -92% | -$11.5M |
|
669
Pixelworks
PXLW
$37.2M
| $1.24M | 0.01% |
36,631
-9,916
| -21% | -$299K |
|
|
ALTA
670
DELISTED
Altabancorp
ALTA
| $1.23M | 0.01% |
44,073
-1,551
| -3% | -$39.4K |
|
671
Hyster-Yale Materials Handling
HY
$576M
| $1.23M | 0.01% |
+20,605
| New | +$1.04M |
|
672
Regenxbio
RGNX
$616M
| $1.23M | 0.01% |
27,048
-1,518
| -5% | -$53K |
|
673
Wabash National
WNC
$504M
| $1.23M | 0.01% |
71,238
| – | – |
|
|
OPLN
674
Openlane
OPLN
$4.28B
| $1.22M | 0.01% |
+65,707
| New | +$1.13M |
|
|
PTN
675
Palatin Technologies
PTN
$14.4M
| $1.22M | 0.01% |
1,448
+558
| +63% | +$319K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2020 Portfolio in Review
As of Q4 2020, Jacobs Levy Equity Management held 1,151 positions worth $11.4B, up 18% from $9.65B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management's Q4 2020 filing shows 138 new, 341 increased, 503 reduced and 146 closed positions. Its largest new stake was DexCom: 229,736 shares worth $21.2M. The largest sale was Optimum Communications Inc, an estimated $41M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q4 2020 buy was DexCom: 229,736 shares worth $21.2M.
- Jacobs Levy Equity Management added most to Amazon in Q4 2020, an estimated $32.1M increase.
- Jacobs Levy Equity Management's biggest Q4 2020 reduction was Qualcomm, cutting an estimated $33.6M.
- Jacobs Levy Equity Management fully exited Optimum Communications Inc in Q4 2020, selling an estimated $41M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $11.4B portfolio in Q4 2020.
- Jacobs Levy Equity Management opened 138 new positions and closed 146 in Q4 2020.
- Jacobs Levy Equity Management's portfolio value rose 18% quarter-over-quarter to $11.4B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2020, filed 16 Feb 2021.